To mimic the inhibitory effect of anlotinib on the progression of lung fibrosis, primary MLFs were pretreated with anlotinib (1 μM) for 3 h and then exposed to TGF-β1 (10 ng/ml) for an additional 24 h. Here, TGFB1 is linked to pulmonary fibrosis.